NCT01053897View on ClinicalTrials.gov

Study of GBT009 for Treatment of Incisional Wounds Following Breast Reconstruction Surgery

PHASE2CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

January 31, 2010

Primary Completion Date

October 31, 2011

Study Completion Date

October 31, 2011

Conditions
Scar Formation
Interventions
BIOLOGICAL

GBT009

Intradermal Injection following surgery

BIOLOGICAL

Placebo

Intradermal Injection following surgery

Trial Locations (2)

Unknown

Garnet BioTherapeutics Investigational Site, Chicago

Garnet BioTherapeutics Investigational Site, Rochester

Sponsors
All Listed Sponsors
lead

Garnet BioTherapeutics, Inc.

INDUSTRY